Skip to content

ANAVEX LIFE SCIENCES CORP

AVXL

Latest QuantConomy context for AVXL: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class
stock
Primary venue
NASDAQ
Recent signals
3
SEC filings
2
Asset profile

ANAVEX LIFE SCIENCES CORP

QuantConomy has a structured record for AVXL. More descriptive asset metadata will appear here when the platform record includes it.

Symbol
AVXL
Name
ANAVEX LIFE SCIENCES CORP
Coverage
3 market/data records
Sources
alphavantage alpaca fmp sec nasdaq openfigi
Latest signal rows

Recent signals for AVXL

Scored rows are pulled from the same signal API used by the digests.

Signal Direction Score Observed Reason
earnings upcoming
neutral
40
Jun 30, 12:00 AM AVXL (Anavex Life Sciences Corp.) is scheduled to report earnings in 2 days on 2026-06-30 (time TBD). Pre-earnings awareness signal: elevated uncertainty/volatility expected into the report — NEUTRAL direction (event marker, not a directional call). Consensus EPS forecast: -0.07.
other event
neutral
70
Jun 26, 11:05 AM AVXL filed 8-K: Other Events - 1 material event - [strong neutral signal]
earnings release
neutral
40
Nov 25, 12:00 AM AVXL filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2025-11-25. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read).

EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).

PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.

Market coverage

Market Exchange Source Asset record
AVXL NASDAQ alphavantage Anavex Life Sciences Corporation
AVXL NASDAQ alpaca Anavex Life Sciences Corp. Common Stock
AVXL NASDAQ fmp Anavex Life Sciences Corp.

Recent insider transactions

Buys, last 90d
0
Sells, last 90d
0
Rows
2
Date Insider Role Type Shares Price Value Filing
Jan 6, 2026 Boenisch Sandra PFO & Treasurer grant 12,500 4 on EDGAR
Jan 6, 2026 MISSLING CHRISTOPHER U President and CEO grant 125,000 4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

Query AVXL context like a database.

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.

No spam, no noise. Just the launch and the occasional preview.

More: All insider trades · How to read a Form 4 · API access